Literature DB >> 21915551

Total joint arthroplasty in patients with hepatitis C.

Aidin Eslam Pour1, Wadih Y Matar, S Mehdi Jafari, James J Purtill, Matthew S Austin, Javad Parvizi.   

Abstract

BACKGROUND: Hepatitis C is present worldwide. Little is known about the outcome of joint arthroplasty in asymptomatic patients with hepatitis C. We evaluated the surgical complications following hip and knee arthroplasty in patients who were seropositive for hepatitis C in a matched study.
METHODS: Seventy-one patients with hepatitis C underwent forty total hip arthroplasties and thirty-two total knee arthroplasties from 1995 to 2006. The patients had normal preoperative liver function tests. Patients with human immunodeficiency virus infection, hepatitis B, and hemophilia were excluded. A control group was matched in a 2:1 ratio with the hepatitis-C group for age, body-mass index, sex, year of surgery, and medical comorbidities, including diabetes, rheumatoid arthritis, and immunosuppressive conditions.
RESULTS: In the group of patients with hepatitis C who were managed with total hip arthroplasty, six patients (15%) had wound complications requiring oral antibiotics or wound irrigation and debridement and four hips (10%) had mechanical complications, including implant loosening or dislocation. In the control group, three patients (3.8%) had wound complications requiring oral antibiotics or irrigation and debridement and three patients (3.8%) had mechanical complications, including dislocation, periprosthetic femoral fracture, and implant failure. In the group of patients with hepatitis C who underwent total knee arthroplasty, three patients (9.4%) had mechanical complications, including loosening and periprosthetic fracture requiring revision. In the control group, three patients (4.7%) had wound complications, one (1.6%) had a deep infection requiring two-stage revision, and one (1.6%) underwent revision because of a mechanical problem. The combined hepatitis-C group had significantly longer hospital stays and higher rates of surgical and mechanical complications, reoperation, and revision.
CONCLUSIONS: Patients with hepatitis C undergoing joint arthroplasty had a higher rate of surgical complications and a longer hospital stay. The reason for the higher rate of complications in this group of patients is unknown, and further investigation is needed. Patients with hepatitis C should be counseled about the potential for a higher incidence of postoperative complications prior to undergoing joint arthroplasty.

Entities:  

Mesh:

Year:  2011        PMID: 21915551     DOI: 10.2106/JBJS.J.00219

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  14 in total

Review 1.  Risk factors for infectious complications after open fractures; a systematic review and meta-analysis.

Authors:  Kirsten Kortram; Hans Bezstarosti; Willem-Jan Metsemakers; Michael J Raschke; Esther M M Van Lieshout; Michael H J Verhofstad
Journal:  Int Orthop       Date:  2017-07-25       Impact factor: 3.075

2.  Surgical treatment of the haemophilic pseudotumour: a single centre experience.

Authors:  Joannis Panotopoulos; Cihan Ay; Klemens Trieb; Philipp T Funovics; Verena Stockhammer; Susanna Lang; Johannes Holinka; Reinhard Windhager; Ingrid Pabinger; Hugo A Wanivenhaus
Journal:  Int Orthop       Date:  2012-07-04       Impact factor: 3.075

3.  Long-term outcomes of primary total knee arthroplasty in patients with hepatitis B virus infection.

Authors:  Ji-Hoon Baek; Su C Lee; Suengryol Ryu; Jin-Woo Kim; Chang H Nam
Journal:  Bone Jt Open       Date:  2022-06

4.  Is Hepatitis C Infection Associated With a Higher Risk of Complications After Total Shoulder Arthroplasty?

Authors:  Jourdan M Cancienne; Ian J Dempsey; Russell E Holzgrefe; Stephen F Brockmeier; Brian C Werner
Journal:  Clin Orthop Relat Res       Date:  2016-07-22       Impact factor: 4.176

5.  Comparison of metal on metal versus polyethylene-ceramic bearing in uncemented total hip arthroplasty in patients with haemophilic arthropathy.

Authors:  Joannis Panotopoulos; Cihan Ay; Reinhard Schuh; Stephan Domayer; Philipp Funovics; Klemens Trieb; Hugo Wanivenhaus; Reinhard Windhager
Journal:  Int Orthop       Date:  2014-04-12       Impact factor: 3.075

6.  What is the success of treatment of hip and knee candidal periprosthetic joint infection?

Authors:  Steve W N Ueng; Ching-Yu Lee; Chih-chien Hu; Pang-Hsin Hsieh; Yuhan Chang
Journal:  Clin Orthop Relat Res       Date:  2013-04-30       Impact factor: 4.176

7.  Outcomes of hip and knee total joint arthroplasty in a Canadian inmate population over a 10-yearzzm321990period

Authors:  Kelly Harper; Gavin Wood; Lalonde Sebastien; Walsh Kellen
Journal:  Can J Surg       Date:  2018-10-01       Impact factor: 2.089

8.  The Impact of Medical Comorbidities on Primary Total Knee Arthroplasty Reimbursements.

Authors:  Karim G Sabeh; Samuel Rosas; Leonard T Buller; Andrew A Freiberg; Cynthia L Emory; Martin W Roche
Journal:  J Knee Surg       Date:  2018-05-23       Impact factor: 2.501

9.  Total joint arthroplasty in patients with chronic infectious liver disease.

Authors:  Jeremy N Truntzer; Kalpit N Shah; Derek R Jenkins; Lee E Rubin
Journal:  Arthroplast Today       Date:  2015-10-31

10.  Hepatitis C infection and complication rates after total shoulder arthroplasty in United States veterans.

Authors:  Favian Su; Charles J Cogan; Ilya Bendich; Ning Zhang; Mary A Whooley; Alfred C Kuo
Journal:  JSES Int       Date:  2021-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.